These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1723912)

  • 1. Fibrinogen-fibrin: preparation and use of monoclonal antibodies as diagnostics.
    Kudryk BJ; Bini A; Rosebrough SF; Schaible TF
    Biotechnology; 1991; 19():281-313. PubMed ID: 1723912
    [No Abstract]   [Full Text] [Related]  

  • 2. Markers of fibrinogen derivatives used in clinical investigation.
    Soria J; Soria C; Mirshahi M; Samama MM
    Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products.
    Amiral J; Grosley M; Mimilla F; Plassart V; Chambrette B
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):447-52. PubMed ID: 1723302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
    Dyr JE; Cajthamlová H; Suttnar J
    Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of fibrinogen/fibrin degradation products (F/F DP)].
    Alakhverdian R
    Vutr Boles; 1979; 18(3):160-7. PubMed ID: 89851
    [No Abstract]   [Full Text] [Related]  

  • 7. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody, specific for human fibrinogen, fibrinopeptide A-containing fragments and not reacting with free fibrinopeptide A.
    Koppert PW; Huijsmans CM; Nieuwenhuizen W
    Blood; 1985 Sep; 66(3):503-7. PubMed ID: 4040783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
    Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
    Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin.
    Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
    Mol Immunol; 1984 Jan; 21(1):89-94. PubMed ID: 6200769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.
    Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
    Mol Immunol; 1983 Nov; 20(11):1191-200. PubMed ID: 6656769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary stability of fibrinogen epitopes implicated in fibrin polymerization and in fibrinolysis.
    Mirshahi M; Mirshahi SS; Soria C; Perrot JY; Guidalia M; Boucheix C; Soria J
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):427-31. PubMed ID: 2133218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of fibrinopeptide A - immunoreactivity of fibrinogen and fibrinogen fragments.
    Kockum C
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):639-46. PubMed ID: 7444867
    [No Abstract]   [Full Text] [Related]  

  • 14. A neoantigenic determinant in the D-dimer fragment of fibrin.
    Lugovskoy EV; Kolesnikova IN; Gritsenko PG; Zolotareva EN; Gaffney P; Nieuwenhuizen W; Komisarenko SV
    Thromb Res; 2002 Aug; 107(3-4):151-6. PubMed ID: 12431482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface markers of fibrinogen and its physiologic derivatives revealed by antibody probes.
    Plow EF; Edgington TS
    Semin Thromb Hemost; 1982 Jan; 8(1):36-56. PubMed ID: 6173923
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterisation of the chains of human fibrinogen isolated by perfusion chromatography using fibrin specific monoclonal antibodies.
    Raut S; Corran PH; Gaffney PJ
    Thromb Res; 1995 Aug; 79(4):405-13. PubMed ID: 7482444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen and fibrin degradation products: their differentiation.
    Edgington TS
    Thromb Diath Haemorrh; 1975 Dec; 34(3):671-6. PubMed ID: 54944
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation and characterization of a monoclonal antibody specific for fibrinogen and fibrin of human origin.
    Sola B; Avner PR; Zilber MT; Connan F; Lévy D
    Thromb Res; 1983 Mar; 29(6):643-53. PubMed ID: 6857603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody specific to the granulocyte-derived elastase-fragment D species of human fibrinogen and fibrin: its application to the measurement of granulocyte-derived elastase digests in plasma.
    Kohno I; Inuzuka K; Itoh Y; Nakahara K; Eguchi Y; Sugo T; Soe G; Sakata Y; Murayama H; Matsuda M
    Blood; 2000 Mar; 95(5):1721-8. PubMed ID: 10688830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and characterization of a monoclonal antibody reactive with a specific neoantigenic determinant (comprising B beta 54-118) in degradation products of fibrin and of fibrinogen.
    Koppert PW; Koopman J; Haverkate F; Nieuwenhuizen W
    Blood; 1986 Aug; 68(2):437-41. PubMed ID: 3730608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.